NUSIRT SCIENCES, INC.
Sirtuin Activation for Aging and Overnutrition | NuSirt Sciences
Harpers Ferry, United States · Founded 2025 · $1.1M raised
- Headquarters
- Harpers Ferry, West Virginia
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B2C
- Website
- nusirt.com
- Total Funding
- $1.1M
About
NuSirt Sciences is a privately held biopharmaceutical company developing combination therapeutics that activate the sirtuin pathway to address metabolic diseases including obesity, diabetes, MAFLD/MASH, and hypertension. Its lead drug candidate TRIPLN combines L-leucine, metformin, and sildenafil, and has shown promising results in Phase 2 clinical trials. NuSirt also produces LEUSIX, a dietary supplement supporting cardiometabolic health and weight management.
Summary
NUSIRT SCIENCES, INC. is a Biotech company based in Harpers Ferry, United States, founded in 2025. It has raised $1.1M in total.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company